Akebia Could Face Long, Costly Effort To Overcome Vadadustat CRL
Company Pins Hopes On Partner Otsuka’s EMA Application
The US FDA turned down approval for vadadustat in chronic kidney disease anemia, in a complete response letter that unexpectedly included the dialysis-dependent indication.
